Volume 28; Issue 1 Suppleme

Main
BioDrugs
Volume 28; Issue 1 Suppleme

BioDrugs

Volume 28; Issue 1 Suppleme

1

Tumour Necrosis Factor α Antagonists in the Treatment of Rheumatoid Arthritis: An Immunological Perspective

Pier-Luigi Meroni,Guido Valesini

Journal:

Year:

2014

Language:

english

File:

PDF, 966 KB

english, 2014

2

Pegylation of Biological Molecules and Potential Benefits: Pharmacological Properties of Certolizumab Pegol

Pasut, Gianfranco

Journal:

Year:

2014

Language:

english

File:

PDF, 522 KB

english, 2014

3

Efficacy and Safety of Certolizumab Pegol in Rheumatoid Arthritis: Meeting Rheumatologists’ Requirements in Routine Clinical Practice

Punzi, Leonardo, Lapadula, Giovanni, Mathieu, Alessandro

Journal:

Year:

2014

Language:

english

File:

PDF, 486 KB

english, 2014

4

How FABulous is PEGgy? Certoliziumab Pegol from the Bench to the Patients

Aletaha, Daniel

Journal:

Year:

2014

Language:

english

File:

PDF, 128 KB

english, 2014

5

Optimisation of TNF-Inhibitor Therapy for Rheumatoid Arthritis: Focus on Certolizumab Pegol

Lyseng-Williamson, Katherine A., Duggan, Sean T., Keating, Gillian M.

Journal:

Year:

2014

File:

PDF, 103 KB

2014